MARKET

JUNS

JUNS

JUPITER NEUROSCIENCES, INC.
NASDAQ
0.8307
-0.0169
-1.99%
After Hours: 0.8500 +0.0193 +2.32% 19:27 02/14 EST
OPEN
0.8400
PREV CLOSE
0.8476
HIGH
0.8550
LOW
0.7802
VOLUME
264.40K
TURNOVER
--
52 WEEK HIGH
19.51
52 WEEK LOW
0.7802
MARKET CAP
27.50M
P/E (TTM)
-36.7566
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at JUNS last week (0203-0207)?
Weekly Report · 4d ago
Jupiter Neurosciences says volatility ‘appears to be driven by misconceptions’
TipRanks · 02/04 14:30
Jupiter Neurosciences Addresses Market Volatility as it Remains Focused on Advancing Clinical and Commercial Milestones
Barchart · 02/04 08:25
Jupiter Neurosciences announces JOTROL manufaturing agreement with Catalent
TipRanks · 02/03 13:15
Jupiter Neurosciences Enters Agreement With Catalent For JOTROL Softgel Production For Phase 2a Parkinson's Clinical Trial
Benzinga · 02/03 13:10
JUPITER NEUROSCIENCES- UNDER TERMS, CATALENT TO MANUFACTURE CLINICAL BATCHES OF JOTROL FOR PARKINSON'S STUDY
Reuters · 02/03 13:00
Weekly Report: what happened at JUNS last week (0127-0131)?
Weekly Report · 02/03 12:47
Jupiter Neurosciences partners with Zina Biopharmaceuticals to advance Phase 2a
TipRanks · 01/30 13:20
More
About JUNS
Jupiter Neurosciences, Inc. is a clinical-stage research and development pharmaceutical company. The Company has developed a resveratrol platform product targeting treatment of neuro-inflammation. Its product, JOTROL, has many potential indications of use for rare diseases, which of it primarily is targeting Mucopolysaccharidoses Type 1, Friedreich's Ataxia, and Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like episodes (MELAS). In the larger disease areas, the Company is primarily targeting Parkinson's Disease and Mild Cognitive Impairment/early Alzheimer’s disease. The Company has designated the different indications with project numbers, JNS101 - JNS115. JOTROL is a micellar non-aqueous solution of resveratrol delivered in a soft gel capsule. Each capsule includes 100 milligrams (mg) of resveratrol. It has a worldwide license, from Aquanova AG, the patent holder of micellar technologies, to develop, manufacture, distribute and sell JOTROL.

Webull offers Jupiter Neurosciences Inc stock information, including NASDAQ: JUNS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, JUNS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading JUNS stock methods without spending real money on the virtual paper trading platform.